CARRIE HANSEN: Open Payments
NPI 1710024963 · CLAREMONT, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 27 payments from 12 companies in 2025. Trend: 2023 $240 · 2024 $436 · 2025 $628
Food & beverage: $529Education: $99
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $108 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Janssen Biotech, Inc. | 4 | $85 |
| ABBVIE INC. | 3 | $83 |
| Regeneron Healthcare Solutions, Inc. | 4 | $76 |
| Galderma Laboratories, L.P. | 3 | $46 |
| Incyte Corporation | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| LEO Pharma Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
Products named: DUPIXENT, OTEZLA, TREMFYA, RINVOQ, NEMLUVIO, OPZELURA, Sotyktu, SPEVIGO.
Industry payments across NH — which companies pay providers there.
